Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor Positive Breast Cancer
Interventions: DRUG: entinostat|DRUG: exemestane
Sponsor: Syndax Pharmaceuticals